
Diclofenac Potassium NEW
Price | $33 | $48 | $131 |
Package | 50mg | 100mg | 500mg |
Min. Order: | |
Supply Ability: | 10g |
Update Time: | 2025-04-29 |
Product Details
Product Name: Diclofenac Potassium | CAS No.: 15307-81-0 |
Purity: 99.51% | Supply Ability: 10g |
Release date: 2025/04/29 |
Product Introduction
Bioactivity
Name | Diclofenac Potassium |
Description | Diclofenac Potassium (CGP-45840B) is a nonsteroidal anti-inflammatory drug taken to reduce inflammation and as an analgesic reducing pain in certain conditions. |
In vitro | The primary mechanism of diclofenac responsible for its anti-inflammatory, antipyretic, and analgesic action is thought to be inhibition of prostaglandin synthesis by inhibition of cyclooxygenase (COX). It also appears to exhibit bacteriostatic activity by inhibiting bacterial DNA synthesis. Inhibition of COX also decreases prostaglandins in the epithelium of the stomach, making it more sensitive to corrosion by gastric acid. This is also the main side effect of diclofenac. Diclofenac has a low to moderate preference to block the COX2-isoenzyme (approximately 10-fold) and is said to have, therefore, a somewhat lower incidence of gastrointestinal complaints than noted with indomethacin and aspirin. |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | H2O : 10 mg/mL (29.92 mM), Sonication is recommended. Ethanol : < 1 mg/mL (insoluble or slightly soluble) DMSO : 55 mg/mL (164.55 mM), Sonication is recommended. |
Keywords | stem | ovine | NSCs | neural | Inhibitor | inhibit | Diclofenac Potassium | Diclofenac | Cyclooxygenase | COX-2 | COX-1 | COX | CHO | cells | caspase | cascade | Apoptosis | anti-inflammatory |
Inhibitors Related | Stavudine | 5-Fluorouracil | Acetylcysteine | Acetaminophen | Sodium 4-phenylbutyrate | L-Ascorbic acid | Dextran sulfate sodium salt (MW 4500-5500) | L-Glutamic acid | Metronidazole | Tributyrin | L-Ascorbic acid sodium salt | Salicylic acid |
Related Compound Libraries | Failed Clinical Trials Compound Library | Pain-Related Compound Library | Anti-Neurodegenerative Disease Compound Library | Bioactive Compound Library | Anti-Cancer Clinical Compound Library | Inhibitor Library | Anti-Cancer Approved Drug Library | FDA-Approved Drug Library | Anti-Aging Compound Library | Immunology/Inflammation Compound Library | Bioactive Compounds Library Max | Anti-Cancer Drug Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$5.00/1KG |
VIP1Y
|
Wuhan JiyunZen Tech Co., Ltd.
|
2025-05-07 | |
$/ |
VIP5Y
|
RongNa Biotechnology Co.,Ltd
|
2025-04-29 | |
$120.00/1KG |
Shandong Xuhuang New material CoLTD
|
2025-02-25 | ||
$10.00/1kg |
VIP7Y
|
Hebei Chuanghai Biotechnology Co., Ltd
|
2024-11-19 | |
$10.00/100kg |
VIP1Y
|
Aurora Industry Co., Ltd.
|
2024-09-05 | |
$1.00/1KG |
VIP4Y
|
Hebei Chuanghai Biotechnology Co,.LTD
|
2024-08-20 | |
$0.00/1kg |
Henan Suikang Pharmaceutical Co.,Ltd.
|
2024-04-26 | ||
$15.00/1kg |
Ouhuang Engineering Materials (Hubei) Co., Ltd
|
2024-04-25 | ||
$120.00/1kg |
Hebei Zhuanglai Chemical Trading Co.,Ltd
|
2024-04-24 | ||
$0.00/1kg |
VIP2Y
|
Shaanxi TNJONE Pharmaceutical Co., Ltd
|
2024-04-08 |
- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY